Medicare Part D, the prescription drug benefit, generally includes coverage for antiviral medications. Paxlovid, an antiviral drug used to treat COVID-19, may be covered under Medicare Part D plans. Specific coverage details, such as cost-sharing and formulary placement, vary among different Part D plans.
Access to treatments like Paxlovid is important for managing COVID-19, particularly for individuals at higher risk of severe illness. The availability of prescription drug coverage facilitates timely access to necessary medications. The history of Medicare Part D highlights its role in ensuring beneficiaries have access to a range of pharmaceuticals, subject to plan-specific rules.
